ReviewJournal of managed care & specialty pharmacy2022

Trends in endpoint use in pivotal trials and efficacy for US Food and Drug Administration-approved solid tumor therapies, 1995-2021.

Orges Alabaku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.